Similar articles

• [Prognostic importance of beta-2-microglobulin in multiple myeloma].

  Avilés A, Zepeda G, Guzmán R, Talavera A, García EL, Díaz-Maqueo JC. Avilés A, et al. Rev Invest Clin. 1992 Apr-Jun;44(2):215-20. Rev Invest Clin. 1992. PMID: 1439309 Spanish.
• Beta-2-microglobulin in multiple myeloma.

  Musarurwa C, Matarira HT. Musarurwa C, et al. Cent Afr J Med. 2004 Jan-Feb;50(1-2):19-20. Cent Afr J Med. 2004. PMID: 15490720 No abstract available.
• Prognosis of asymptomatic multiple myeloma.

  Alexanian R, Barlogie B, Dixon D. Alexanian R, et al. Arch Intern Med. 1988 Sep;148(9):1963-5. Arch Intern Med. 1988. PMID: 2458080
• [Prognostic factors in multiple myeloma].

  Boccadoro M, Bianchi A, Dianzani U, Frieri R, Gallone G, Massaia M, Omede P, Palumbo A, Pileri A. Boccadoro M, et al. Haematologica. 1989 Oct;74(5 Suppl):347-57. Haematologica. 1989. PMID: 2512219 Review. Italian. No abstract available.
• [Classification, staging and prognostic indices for multiple myeloma].

  Hotta T. Hotta T. Nihon Rinsho. 2007 Dec;65(12):2161-6. Nihon Rinsho. 2007. PMID: 18069256 Review. Japanese.